Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
FDF
0
FDA Orange Book
0
Europe
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Cga 184699
2. Cga-184699
3. Fluphenacur
4. Fluphenacur, Monosodium Salt
5. N-(2,5-dichloro-4-(1,1,2,3,3,3-hexafluoropropoxy)phenylaminocarbonyl)-2,6-difluorobenzamide
1. 103055-07-8
2. Fluphenacur
3. Lufenuron, (+)-
4. Lufenuron, (-)-
5. 1-(2,5-dichloro-4-(1,1,2,3,3,3-hexafluoropropoxy)phenyl)-3-(2,6-difluorobenzoyl)urea
6. 130841-26-8
7. Cga-184699
8. Nsc-759097
9. N-((2,5-dichloro-4-(1,1,2,3,3,3-hexafluoropropoxy)phenyl)carbamoyl)-2,6-difluorobenzamide
10. N-[[2,5-dichloro-4-(1,1,2,3,3,3-hexafluoropropoxy)phenyl]carbamoyl]-2,6-difluorobenzamide
11. 9cr45yms74
12. 130841-22-4
13. Chebi:39384
14. N-{[2,5-dichloro-4-(1,1,2,3,3,3-hexafluoropropoxy)phenyl]carbamoyl}-2,6-difluorobenzamide
15. Benzamide, N-(((2,5-dichloro-4-(1,1,2,3,3,3-hexafluoropropoxy)phenyl)amino)carbonyl)-2,6-difluoro-, (+)-
16. Benzamide, N-(((2,5-dichloro-4-(1,1,2,3,3,3-hexafluoropropoxy)phenyl)amino)carbonyl)-2,6-difluoro-, (-)-
17. Ncgc00095978-02
18. 1r754m4918
19. 4629851k7q
20. Dsstox_cid_14357
21. Dsstox_rid_79146
22. Dsstox_gsid_34357
23. Benzamide, N-[[[2,5-dichloro-4-(1,1,2,3,3,3-hexafluoropropoxy)phenyl]amino]carbonyl]-2,6-difluoro-
24. N-({[2,5-dichloro-4-(1,1,2,3,3,3-hexafluoropropoxy)phenyl]amino}carbonyl)-2,6-difluorobenzamide
25. Lufenurone
26. Lufenuronum
27. Cigna
28. Match (pesticide)
29. 3-[2,5-dichloro-4-(1,1,2,3,3,3-hexafluoropropoxy)phenyl]-1-[(2,6-difluorophenyl)carbonyl]urea
30. Lufenuron;(rs)-1-[2,5-dichloro-4-(1,1,2,3,3,3-hexafluoropropoxy) Phenyl]-3-(2,6-difluorobenzoyl) Urea
31. N-(2,5-dichloro-4-(1,1,2,3,3,3-hexafluoropropoxy)-phenyl-aminocarbonyl)-2,6-difluorobenzamide
32. N-[2,5-dichloro-4-(1,1,2,3,3,3-hexafluoropropoxy)-phenyl-aminocarbonyl]-2,6-difluorobenzamide
33. Program Flavor Tabs
34. Program
35. Cas-103055-07-8
36. Lufenuron [inn:ban]
37. Lufenurone [inn-french]
38. Lufenuronum [inn-latin]
39. Unii-1r754m4918
40. N-(((2,5-dichloro-4-(1,1,2,3,3,3-hexafluoropropoxy)phenyl)amino)carbonyl)-2,6-difluorobenzamide
41. Cga 184699
42. Lufenuron (usp/inn)
43. Lufenuron [inn]
44. Lufenuron [mi]
45. Lufenuron [mart.]
46. Ec 410-690-9
47. Lufenuron [usp-rs]
48. Program [veterinary] (tn)
49. Unii-9cr45yms74
50. Schembl27105
51. Bspbio_002424
52. Mls004712069
53. Spectrum1505355
54. Lufenuron [green Book]
55. Chembl1364906
56. Dtxsid5034357
57. Lufenuron [usp Monograph]
58. Hms3264n09
59. Pharmakon1600-01505355
60. Unii-4629851k7q
61. Sentinel Component Lufenuron
62. Bcp15961
63. Tox21_111542
64. Tox21_300907
65. Mfcd00867616
66. Nsc759097
67. Lufenuron 100 Microg/ml In Methanol
68. Akos022185021
69. Lufenuron Component Of Sentinel
70. Tox21_111542_1
71. Ccg-213976
72. Db11424
73. Nsc 759097
74. N-[[2,5-dichloro-4-(1,1,2,3,3,3-hexafluoropropoxy)phenyl]carbamoyl]-2,6-difluoro-benzamide
75. Lufenuron 100 Microg/ml In Acetonitrile
76. Ncgc00095978-01
77. Ncgc00095978-03
78. Ncgc00095978-04
79. Ncgc00095978-06
80. Ncgc00254811-01
81. As-13363
82. Smr001563631
83. Lufenuron 1000 Microg/ml In Acetonitrile
84. Sbi-0207025.p001
85. Db-040412
86. Hy-115584
87. Cs-0088780
88. Ft-0631021
89. L0358
90. Lufenuron, Pestanal(r), Analytical Standard
91. C18434
92. D08150
93. E78989
94. Ab01563233_01
95. Lufenuron (anhydrous) For Veterinary Use
96. 055l078
97. A800670
98. Q412933
99. Sr-01000872762
100. J-521659
101. Sr-01000872762-1
102. Brd-a71774530-001-01-8
103. Brd-a71774530-001-02-6
104. Lufenuron, European Pharmacopoeia (ep) Reference Standard
105. Lufenuron (anhydrous) For Veterinary Use [ep Impurity]
106. Lufenuron, United States Pharmacopeia (usp) Reference Standard
107. Lufenuron For Peak Identification, European Pharmacopoeia (ep) Reference Standard
108. N-(2,5-dichloro-4-(1,1,2,3,3,3-hexafluoropropoxy)phenylcarbamoyl)-2,6-difluorobenzamide
109. N-[[2,5-dichloro-4-(1,1,3,4,4,4-hexafluorobutyl)phenyl]carbamoyl]-2,6-difluoro-benzamide
110. (+)-n-(((2,5-dichloro-4-(1,1,2,3,3,3-hexafluoropropoxy)phenyl)amino)carbonyl)-2,6-difluorobenzamide
111. (-)-n-(((2,5-dichloro-4-(1,1,2,3,3,3-hexafluoropropoxy)phenyl)amino)carbonyl)-2,6-difluorobenzamide
112. (rs)-1-(2,5-dichloro-4-(1,1,2,3,3,3-hexafluoropropoxy)phenyl)-3-(2,6-difluorobenzoyl)urea
113. 1-(2,5-dichloro-4-(1,1,2,3,3,3-hexafluoropropoxy)phenyl)-3-(2,6-difluorobenzoyl)-urea
114. Benzamide,n-[[[2,5-dichloro-4-(1,1,2,3,3,3-hexafluoropropoxy)phenyl]amino]carbonyl]-2,6-difluoro-
Molecular Weight | 511.1 g/mol |
---|---|
Molecular Formula | C17H8Cl2F8N2O3 |
XLogP3 | 6.4 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 11 |
Rotatable Bond Count | 5 |
Exact Mass | 509.9784228 g/mol |
Monoisotopic Mass | 509.9784228 g/mol |
Topological Polar Surface Area | 67.4 Ų |
Heavy Atom Count | 32 |
Formal Charge | 0 |
Complexity | 677 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Insecticides
Pesticides designed to control insects that are harmful to man. The insects may be directly harmful, as those acting as disease vectors, or indirectly harmful, as destroyers of crops, food products, or textile fabrics. (See all compounds classified as Insecticides.)
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Lufenuron manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Lufenuron, including repackagers and relabelers. The FDA regulates Lufenuron manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Lufenuron API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Lufenuron manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Lufenuron supplier is an individual or a company that provides Lufenuron active pharmaceutical ingredient (API) or Lufenuron finished formulations upon request. The Lufenuron suppliers may include Lufenuron API manufacturers, exporters, distributors and traders.
click here to find a list of Lufenuron suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Lufenuron as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Lufenuron API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Lufenuron as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Lufenuron and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Lufenuron NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Lufenuron suppliers with NDC on PharmaCompass.
Lufenuron Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Lufenuron GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Lufenuron GMP manufacturer or Lufenuron GMP API supplier for your needs.
A Lufenuron CoA (Certificate of Analysis) is a formal document that attests to Lufenuron's compliance with Lufenuron specifications and serves as a tool for batch-level quality control.
Lufenuron CoA mostly includes findings from lab analyses of a specific batch. For each Lufenuron CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Lufenuron may be tested according to a variety of international standards, such as European Pharmacopoeia (Lufenuron EP), Lufenuron JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Lufenuron USP).
LOOKING FOR A SUPPLIER?